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Hedyotis (Family, Rubiaceae) is a genus of erect decumbent or climbing herbs. The   
genus consists of some 180 species. They  grow  well on dry and sandy soil, along 
rivers and coasts and in the forests. There are 35 species recorded in Malaysia. Most 
of the species possess medicinal properties and are used by the Malay as well as the 
Chinese communities.  
 
The methanolic extracts of seven Hedyotis species including H. capitellata (stems, 
leaves and roots), H. dichotoma (aerial parts and roots), H. verticillata (leaves and 
stems), H. herbacea (aerial parts), H. pinifolia (aerial parts), H. corymbosa (aerial 
parts) and H. nudicaulis (aerial parts) were screened for antioxidant, radical-
scavenging, anti-inflammatory, cytotoxic as well as anti-bacterial properties using 
the ferric thiocyanate (FTC) and thiobarbituric acid (TBA), the diphenylpicryl 
hydrazyl (DPPH), the Griess assay, the MTT assay and the disc diffusion methods, 
respectively. The results showed that all of the extracts tested possess strong 
antioxidant potential. However, they are poor radical scavengers and nitric oxide 
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inhibitors. They are also found to be weakly cytotoxic and possess weak to moderate 
antibacterial properties. On the basis of the screening results and literature review, H. 
capitellata (stems) was selected for further phytochemical study. 
 
Phytochemical investigation on the active fraction of the stems of H. capitellata plant 
yielded fifteen compounds. The structure of the compounds was elucidated based on 
spectroscopic techniques and comparison with literature values. Eight compounds 
are new furanoanthraquinones named capitellataquinone A-G and epi-
capitellataquinone E. A new anthraquinone, 2,8-dihydroxy-1-methoxyanthraquinone 
together with rubiadin, alizarin 1-methyl ether, anthragallol 2-methyl ether, 
digiferruginol and scopoletin were also isolated. From the roots of the plant, lucidin 
3-O-β-glucoside was also isolated. The isolation of an  anthraquinone glycoside is a 
first for the genus.  
 
Antioxidant assays on ten compounds including capitellataquinones A, B, E, F, epi-
capitellataquinone E, rubiadin, alizarin 1-methyl ether, anthragallol 2-methyl ether, 
digiferruginol and scopoletin showed that capitellataquinone A and scopoletin 
possess strong antioxidant properties with percent inhibition of 94-96% compared to 
quercetin (98%). MTT cytotoxic assays of the same compounds tested showed weak 
cytotoxicity to most cell-lines with IC50 values of 24-40 µg/ml. However, alizarin 1-
methyl ether was found to be selectively cytotoxic against MDA-MB-231 with an 
IC50 value of 8 µg/ml.  
 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia bagi 
memenuhi keperluan ijazah Doktor Falsafah 
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Hedyotis (Famili Rubiaceae) ialah genus tumbuhan herba yang tumbuh menegak 
atau memanjat. Genus ini terdiri daripada 180 spesies. Ia tumbuh dengan baik di 
tanah yang kering dan berpasir, di tepi pantai dan di dalam hutan. Terdapat 35 
spesies yang direkodkan di Malaysia. Kebanyakan daripadanya mempunyai nilai 
perubatan dan digunakan oleh kaum Melayu dan Cina.  
 
Ekstrak metanol tujuh spesies Hedyotis termasuk H. capitellata (daun, batang dan 
akar), H. dichotoma (atas dan akar), H. verticillata (atas dan batang), H. herbacea 
(atas), H. pinifolia (daun), H. corymbosa (atas) dan H. nudicaulis (atas)  disaring 
untuk sifat antioksida, anti-inflamasi, sitotoksik dan anti-bakteria menggunakan 
biocerakinan ferrik tiosianat (FTC) dan asid tiobarbiturik (TBA), kaedah 
difenilpikrilhidrazil (DPPH), kaedah Griess, kaedah MTT dan kaedah pembauran 
cakera, masing-masing. Keputusan biocerakinan menunjukkan bahawa kesemua 
ekstrak mempunyai potensi antioksidaan yang kuat. Walau bagaimana pun, 
kesemuanya merupakan  pemerangkap radikal dan perencat nitrik oksida yang 
lemah. Mereka juga didapati mempunyai sifat sititoksik yang sederhana serta 
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mempunyai sifat antibakteria lemah hingga sederhana. Berdasarkan keputusan 
penyaringan dan kajian literatur, H. capitellata (batang) telah dipilih untuk fitokimia. 
 
Penyelidikan fitokimia ke atas fraksi aktif batang H. capitellata menghasilkan lima 
belas sebatian. Struktur kesemua sebatian dikenalpasti berdasarkan kaedah 
spektroskopi dan perbandingan dengan literatur. Lapan sebatian merupakan 
furanoantrakuinon baru yang dinamakan capitellataquinone A-G dan epi-
capitellataquinone E. Satu antrakuinon baru, 2,8-dihidroksi-1-metoksiantrakuinon 
bersama dengan rubiadin, alizarin 1-metil eter, antragalol 2-metil eter, digiferuginol 
dan skopoletin juga berjaya dipencilkan. Daripada bahagian akar tumbuhan tersebut, 
lucidin 3-O-β-glukosida telah dipencilkan. Ini adalah kali pertama anthrakuinon 
glikosida dipencilkan daripada genus ini.  
 
Cerakinan antioksidaan terhadap sepuluh sebatian termasuk capitellatakuinon A, B, 
E, F, epi-capitellatakuinon E, rubiadin, alizarin 1-metil ether, anthragallol 2-metil 
ether, digiferruginol dan skopoletin menunjukkan bahawa hanya capitellatakuinon A 
dan skopoletin menunjukkan sifat antioksidaan yang baik dengan peratus hindaran 
sebanyak 94-96% berbanding dengan quercetin (98%). Cerakinan sitotoksik MTT 
keatas sebatian yang sama menunjukkan sifat sitotoksik yang lemah terhadap 
kebanyakan titisan sel dengan nilai IC50 antara 24-40 µg/ml. Walau bagaimana pun, 
alizarin 1-metil eter didapati sitotoksik secara selektif terhadap MDA-MB-231 
dengan nilai IC50 8 µg/ml.  
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